Arcutis Biotherapeutics, Inc. (ARQT)
28.36
+0.28
(+1.00%)
USD |
NASDAQ |
Dec 31, 09:30
Arcutis Biotherapeutics EPS Diluted (Quarterly): 0.0558 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CorMedix, Inc. | 1.259 |
| ADMA Biologics, Inc. | 0.1489 |
| ANI Pharmaceuticals, Inc. | 1.133 |
| Editas Medicine, Inc. | -0.2788 |
| Amicus Therapeutics, Inc. | 0.0558 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 7.41M |
| Revenue (Quarterly) | 99.22M |
| Total Expenses (Quarterly) | 91.81M |
| Enterprise Value | 3.362B |
| Gross Profit Margin (Quarterly) | 91.25% |
| Profit Margin (Quarterly) | 7.47% |
| Earnings Yield | -1.25% |
| Normalized Earnings Yield | -1.254 |